Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one of the longevity field's most promising theories. Why it matters: The ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. A first-of-its-kind shot that promises to reverse aging was just injected into a human body. It's a ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...